Tag: INVOKANA
Canagliflozin and Amputation Risk: What You Need to Know Today
Canagliflozin (INVOKANA) carries a documented risk of lower-limb amputation, especially in patients with foot or circulation problems. Learn who’s at risk, how it compares to other diabetes drugs, and what steps to take to stay safe.